{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:39:19Z","timestamp":1761100759190},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.thromres.2004.12.010","type":"journal-article","created":{"date-parts":[[2005,1,27]],"date-time":"2005-01-27T12:53:17Z","timestamp":1106830397000},"page":"233-240","source":"Crossref","is-referenced-by-count":34,"title":["Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation"],"prefix":"10.1016","volume":"116","author":[{"given":"Verena","family":"Pihusch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Pihusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Penovici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erhard","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Pihusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2004.12.010_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.thromres.2004.12.010_bib2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.thromres.2004.12.010_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10428199709114163","article-title":"Venoocclusive disease of the liver after bone marrow transplantation: the role of hemostasis","volume":"25","author":"Faioni","year":"1997","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.thromres.2004.12.010_bib4","first-page":"3599","volume":"15","author":"Carreras","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2004.12.010_bib5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V75.4.1011.1011","article-title":"Increased serum levels of tumor necrosis factor \u03b1 precede major complications of bone marrow transplantation","volume":"75","author":"Holler","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.12.010_bib6","first-page":"3","article-title":"Natural production and release of tumor necrosis factor","volume":"131","author":"Gifford","year":"1987","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.thromres.2004.12.010_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/sj.bmt.1701402","article-title":"Plasma thrombopoietin levels in marrow transplantant patients with veno-occlusive disease of the liver","volume":"22","author":"Oh","year":"1998","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.thromres.2004.12.010_bib8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/blood.V67.6.1773.1773","article-title":"Thrombocytopenia in venoocclusive disease after bone marrow transplantation or chemotherapy","volume":"67","author":"Rio","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.12.010_bib9","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI107470","article-title":"Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria","volume":"52","author":"Jaff\u00e9","year":"1973","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2004.12.010_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000469153","article-title":"Plasminogen activator inhibitors\u2014a review","volume":"40","author":"Kruithof","year":"1988","journal-title":"Enzyme"},{"issue":"2","key":"10.1016\/j.thromres.2004.12.010_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.V69.2.381.381","article-title":"Plasminogen activator inhibitors","volume":"69","author":"Sprengers","year":"1987","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2004.12.010_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-2007-1002412","article-title":"Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo","volume":"18","author":"Krishnamurti","year":"1992","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2004.12.010_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/00365518509155267","article-title":"The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast acting inhibitor of tissue-type plasminogen activator after trauma","volume":"45","author":"Kluft","year":"1985","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.thromres.2004.12.010_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002770050364","article-title":"Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications","volume":"76","author":"N\u00fcrnberger","year":"1998","journal-title":"Ann. Hematol."},{"issue":"1-2","key":"10.1016\/j.thromres.2004.12.010_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10428199909093722","article-title":"The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation","volume":"33","author":"Salat","year":"1999","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.thromres.2004.12.010_bib16","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","article-title":"Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation","volume":"89","author":"Salat","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.12.010_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bmt.1701445","article-title":"Relevance of proteins C and S, antithrombin III, von Willebrand factor and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study","volume":"22","author":"Lee","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.thromres.2004.12.010_bib18","first-page":"39","article-title":"Changes in the natural anticoagulants following bone marrow transplantation","volume":"5","author":"Harper","year":"1990","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.thromres.2004.12.010_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1600-0609.2000.9r200.x","article-title":"Venoocclusive disease of the liver after hemopoietic cell transplantation","volume":"64","author":"Carreras","year":"2000","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2004.12.010_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1182\/blood.V86.3.890.890","volume":"86","author":"Holler","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.12.010_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/10428199709114161","article-title":"Inflammatory reactions induced by pretransplant conditioning\u2014an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation?","volume":"25","author":"Holler","year":"1996","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.thromres.2004.12.010_bib22","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1182\/blood.V72.5.1467.1467","article-title":"Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo","volume":"72","author":"Van Hinsberg","year":"1998","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2004.12.010_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0024-3205(96)00265-2","article-title":"Effects of lipopolysaccharide on the expression of fibrinolytic factors in an established cell line from human endothelial cells","volume":"59","author":"Matsumoto","year":"1996","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.thromres.2004.12.010_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01052891","article-title":"Modulation of fibrinolysis by ionizing radiation","volume":"22","author":"Rao","year":"1994","journal-title":"J. Neuro-Oncol."},{"issue":"6667","key":"10.1016\/j.thromres.2004.12.010_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.thromres.2004.12.010_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.182.1.33","article-title":"Expression of functional CD40 by vascular endothelial cells","volume":"132","author":"Hollenbaugh","year":"1995","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.thromres.2004.12.010_bib27","first-page":"1008","article-title":"Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40","volume":"80","author":"Slupsky","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.12.010_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1083\/jcb.111.2.743","article-title":"Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro","volume":"111","author":"Pepper","year":"1990","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.thromres.2004.12.010_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bjo.84.4.417","article-title":"Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells","volume":"84","author":"Wileman","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.thromres.2004.12.010_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1359-6101(99)00037-4","article-title":"TGF \u03b2 in blood: a complex problem","volume":"11","author":"Grainger","year":"2000","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.thromres.2004.12.010_bib31","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.leu.2401477","article-title":"Effects of TGF \u03b2 on the immune system: implications for cancer immunotherapy","volume":"13","author":"DeVisser","year":"1999","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.thromres.2004.12.010_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00000658-199508000-00007","article-title":"Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor","volume":"222","author":"Kong","year":"1995","journal-title":"Ann. Surg."},{"issue":"8","key":"10.1016\/j.thromres.2004.12.010_bib33","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1182\/blood.V83.8.2383a.2383a","article-title":"Transforming growth factor-beta plasma concentrations in patients with leukemia and lymphoma receiving chemoradiotherapy and marrow transplantation","volume":"83","author":"Murase","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2004.12.010_bib34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0008-6363(97)00033-3","article-title":"Transforming growth factor beta 1 and coronary artery disease","volume":"34","author":"Wang","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2004.12.010_bib35","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1073\/pnas.88.15.6642","article-title":"Transforming growth factor \u03b2-1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis","volume":"88","author":"Broekelmann","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"14","key":"10.1016\/j.thromres.2004.12.010_bib36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJM199104043241401","article-title":"Transforming growth factors \u03b2-1 and \u03b1 in chronic liver disease: effects of interferon alfa therapy","volume":"324","author":"Castilla","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 39","key":"10.1016\/j.thromres.2004.12.010_bib37","first-page":"47","article-title":"Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo","volume":"43","author":"Floege","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2004.12.010_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10428199509054751","article-title":"TGF-\u03b2 and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders","volume":"20","author":"Martyr\u00e9","year":"1995","journal-title":"Leuk. Lymphoma"},{"issue":"22","key":"10.1016\/j.thromres.2004.12.010_bib39","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM199306033282203","article-title":"Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer","volume":"328","author":"Anscher","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2004.12.010_bib40","first-page":"173","article-title":"Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity","volume":"15","author":"Murase","year":"1995","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.thromres.2004.12.010_bib41","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","article-title":"Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms","volume":"19","author":"Shulman","year":"1994","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.thromres.2004.12.010_bib42","first-page":"549","article-title":"Hepatic veno-occlusive disease after bone marrow transplantation: immunohistochemical identification of the material within occluded central venules","volume":"127","author":"Shulman","year":"1987","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.thromres.2004.12.010_bib43","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1046\/j.1365-2141.2002.03748.x","article-title":"Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulfan and cyclophosphamide","volume":"118","author":"Lee","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2004.12.010_bib44","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.thromres.2004.12.010_bib45","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.12.010_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00609244","article-title":"Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man","volume":"35","author":"Coccheri","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.thromres.2004.12.010_bib47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.TP.0000136988.38919.FB","article-title":"Impact of thrombophilic gene mutations and graft versus host disease on thromboembolic complications following allogeneic hematopoetic stem cell transplantation","volume":"78","author":"Pihusch","year":"2004","journal-title":"Transplantation"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804006371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804006371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T12:57:39Z","timestamp":1586091459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384804006371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0049384804006371"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2004.12.010","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}